Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Other Non-Current Assets (2014 - 2026)

Updated

Skye Bioscience's Other Non-Current Assets was $8,309 in Q2 2026, down 84.6% from $53,910 a year earlier and down 76.9% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Other Non-Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Skye Bioscience came in at $53,910, unchanged from FY2024.

  • Other Non-Current Assets shows a four-year compound annual growth rate of 59.6% (FY2021 to FY2025).
  • In earlier years, Other Non-Current Assets was $53,910 in FY2024 (+548.8%), $8,309 in FY2023 (unchanged), $8,309 in FY2022 (unchanged) and $8,309 in FY2021.
  • Quarterly Other Non-Current Assets has moved between $8,309 (Q3 2021) and $53,910 (Q4 2025) over five years.
  • Compared with a year earlier, Other Non-Current Assets was higher in five of the last eight quarters, with growth averaging 231.3%.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q2 2025 (growth of 548.8%); the worst was Q2 2026 (a decline of 84.6%).
  • Per Business Quant data, SKYE's Other Non-Current Assets in the three quarters before Q2 2026 was $35,909 (Q1 2026), $53,910 (Q4 2025) and $53,910 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 15.10 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.42 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 700.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.90 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 10.02 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn - 8,309.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8,309.00
Jun 30, 2026 8,309.00
Mar 31, 2026 35,909.00
Dec 31, 2025 53,910.00
Sep 30, 2025 53,910.00
Jun 30, 2025 53,910.00
Mar 31, 2025 53,910.00
Dec 31, 2024 53,910.00
Sep 30, 2024 26,310.00
Jun 30, 2024 8,309.00
Mar 31, 2024 8,309.00
Dec 31, 2023 8,309.00
Sep 30, 2023 8,309.00
Jun 30, 2023 8,309.00
Mar 31, 2023 8,309.00
Dec 31, 2022 8,309.00
Sep 30, 2022 8,309.00
Jun 30, 2022 8,309.00
Mar 31, 2022 8,309.00
Dec 31, 2021 8,309.00
API Access

Skye Bioscience Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SKYE&period=max&api_key=YOUR_API_KEY